Pediatric Croup Treatment

Classify illness clinically before treatment: mild croup has stridor without intercostal retractions, whereas moderate-to-severe disease includes increased work of breathing. Stridor at rest, chest-wall indrawing, biphasic stridor, decreased air entry, or hypoxia should move management from outpatient steroid treatment to nebulized epinephrine plus observation. ScienceDirect+1ScienceDirectRacemic Epinephrine - an overviewPubMedViral croup: diagnosis and a treatment algorithm. - Abstract

Give supplemental oxygen for diminished oxygen saturation. In croup, hypoxemia is not a routine feature of uncomplicated upper-airway disease; it signals severe obstruction and possible impending respiratory failure. A child with hypoxia, markedly decreased air entry, escalating fatigue, or inadequate response to repeated epinephrine requires admission-level monitoring and consideration of intensive care support. ScienceDirect+2ScienceDirectNebulized Budesonide - an overviewScienceDirectRacemic Epinephrine - an overviewPubMedCroup - StatPearls - NCBI Bookshelf

Reconsider the diagnosis rather than repeatedly treating presumed viral croup when the presentation is atypical or deterioration is disproportionate. Important alternatives include bacterial tracheitis, epiglottitis, foreign-body aspiration, peritonsillar abscess, retropharyngeal abscess, and angioedema. ScienceDirectScienceDirectThe assessment and management of croup

Administer dexamethasone once to children who present for medical care with croup, including mild disease. In mild croup, a single oral dose produced small but clinically important clinical and economic benefits. Across croup severity, corticosteroid treatment reduces symptoms, subsequent treatments, hospitalization-related outcomes, and return visits. NEJM+3NEJMA Randomized Trial of a Single Dose of Oral Dexamethasone for ...ScienceDirectThe assessment and management of croupPubMedCommon Pediatric Respiratory EmergenciesPubMedThe role of corticosteroids in the treatment of croup. - Abstract

A commonly used dexamethasone regimen is 0.6 mg/kg once, maximum 10 mg, administered orally, intramuscularly, or intravenously; choose oral therapy when the child can take it. In moderate outpatient croup, a single oral dose was not inferior to intramuscular dosing for subsequent intervention in one study. Reserve intramuscular or intravenous administration for vomiting, inability to tolerate oral medication, or severe respiratory distress. PubMed+2PubMedOutpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. - AbstractPubMedCommon Pediatric Respiratory EmergenciesPubMedThe role of corticosteroids in the treatment of croup. - Abstract

Dose selection remains a practical area of variation. Doses of 0.15-0.6 mg/kg are described in treatment algorithms, and randomized hospitalized-croup data found 0.15 mg/kg orally comparable with 0.3 and 0.6 mg/kg for symptom outcomes, hospitalization duration, epinephrine use, intensive care use, and recurrence-related care. When an institutional pathway specifies 0.6 mg/kg, that regimen has the broadest historic use; lower-dose regimens are supported by comparative trial data. ScienceDirect+3ScienceDirectThe assessment and management of croupPubMedCommon Pediatric Respiratory EmergenciesPubMedViral croup: diagnosis and a treatment algorithm. - AbstractPubMedOral dexamethasone in the treatment of croup: 0.15 mg/kg versus ...

For moderate-to-severe croup, administer nebulized epinephrine together with dexamethasone. Appropriate triggers include stridor at rest, retractions, biphasic stridor, decreased air entry, or hypoxia. Nebulized epinephrine improves croup scores within 30 minutes versus placebo, but does not alter the underlying disease course. ScienceDirect+3ScienceDirectRacemic Epinephrine - an overviewPubMedCroup - StatPearls - NCBI BookshelfPubMedViral croup: diagnosis and a treatment algorithm. - AbstractPubMedNebulized epinephrine for croup in children - PubMed

Use either racemic epinephrine 2.25%, 0.5 mL diluted in 2.5 mL normal saline, or L-epinephrine 1:1,000, 5 mL by nebulizer. Weight-based regimens described for smaller children are racemic epinephrine 0.05 mL/kg of 2.25% solution to a maximum of 0.5 mL, or L-epinephrine 0.5 mL/kg of 1:1,000 solution to a maximum of 5 mL. Available comparative evidence does not favor racemic over L-epinephrine. ScienceDirect+3ScienceDirectNebulized Budesonide - an overviewPubMedThe Outcome of Immediate Administration of Dexamethasone in Children With Croup (Laryngotracheobronchitis) in King Abdullah Specialized Children’s Hospital - PMCpublications aapCroup (Acute Laryngotracheobronchitis) (Chapter 352)PubMedNebulized epinephrine for croup in children - PubMed

Expect benefit to be transient: the effect generally lasts 1-2 hours. Pallor and tachycardia are usually mild and transient, but the clinically important safety issue is recurrence of obstruction as the medication effect wanes. Repeat nebulized epinephrine for persistent severe symptoms while arranging higher-acuity care if response remains inadequate. ScienceDirect+1ScienceDirectNebulized Budesonide - an overviewScienceDirectRacemic Epinephrine - an overview

Observe children after nebulized epinephrine for at least 2 hours; 2-4 hours is a commonly recommended post-treatment monitoring interval, and some emergency-care guidance uses 4 hours. The purpose is to identify recurrent stridor at rest or increased work of breathing after the medication effect dissipates. ScienceDirect+2ScienceDirectRacemic Epinephrine - an overviewPubMedClinical advances in racemic epinephrine for pediatric croup: a mini-review of evidence and practicePubMedCommon Pediatric Respiratory Emergencies

Discharge is appropriate after sustained clinical improvement with no stridor at rest. Children with mild symptoms and no stridor at rest can generally be discharged after dexamethasone if they remain stable. In observational outpatient cohorts treated with racemic epinephrine plus dexamethasone, children discharged after 3-4 hours of observation had no reported short-term return visits in the cited cohorts, although these data are observational. PubMed+1PubMedClinical advances in racemic epinephrine for pediatric croup: a mini-review of evidence and practicePubMedCommon Pediatric Respiratory Emergencies

Admit or extend observation when moderate croup does not improve adequately within 4-6 hours after corticosteroid treatment, when repeated epinephrine is required, or when severe symptoms persist. Escalate to intensive care support when the child has an insufficient response to repeated treatment or features of respiratory failure. ScienceDirect+1ScienceDirectNebulized Budesonide - an overviewPubMedCroup - StatPearls - NCBI Bookshelf